Prescriva review
By Aminoscope editorial desk · Aminoscope
Separate monthly and long plans
Our verdict
Prescriva advertises month-to-month compounded semaglutide injections at $249 and tirzepatide at $339. Lower monthly equivalents require longer plans whose complete payment and exit terms remain unclear. Its public pages name a clinical network and possible pharmacies, but conflicting refund language means medical disqualification should not be treated as a guaranteed full refund.
Main trade-offs
- Long-plan total and exit terms unresolved
- Residual price banners conflict
Disclosure: Aminoscope is reader-supported. We may earn a commission from partner links, at no extra cost to you. This never changes our assessment. How we make money.
Compounded medicines are not FDA-approved. A licensed clinician must assess whether treatment is appropriate; availability does not establish safety or benefit.
Good fit
Adults comparing monthly compounded injection offers who will confirm the care assignment and obtain written payment and refund terms.
Consider other options if
People relying on the smallest banner as a flexible monthly rate or needing a guaranteed full medical-denial refund.
Cost and care at a glance
- Category
- GLP-1 telehealth
- Published cost
- Month-to-month sema $249/mo, tirz $339/mo; longer-plan equivalents and refund scopes differ
- Medications
- Compounded semaglutide · Compounded tirzepatide
- Availability
- All 50 states and DC advertised, subject to service, clinician and dispensing availability
Our review in detail
Full assessment
Prescriva offers a clearer month-to-month comparison than its lowest headline suggests. Choose only after confirming the selected payment schedule, dose coverage and refund scope; the longer-plan equivalents and residual pricing banners are insufficient to establish the total obligation.
What it is
Prescriva LLC describes itself as a California management services organization. Its terms and telehealth consent attribute clinical services to the independent OpenLoop Health network and affiliated professional corporations. This distinguishes administrative support from prescribing responsibility, but the observed pages do not identify every state-specific treating practice. Ask which legal practice and clinician would handle your care and how to reach that team after enrollment. The terms name RedRock Pharmacy, Health Warehouse and Precision Medicine as possible pharmacies. Selection is made for the order and may change; this list does not establish that all three dispense every advertised preparation. Request the actual dispensing pharmacy before comparing fulfillment arrangements. These are Prescriva’s partner disclosures, not independent verification of licensing, accreditation or clinical quality. A named network is useful for directing questions, while the prescription label and assigned practice remain essential for knowing who is responsible for treatment and dispensing.
How care works
The product pages describe a consultation, compounded injection when prescribed, shipping, ongoing support and monthly dose adjustments within the advertised offer. The consent places clinician consultation after checkout, so payment and completion of an intake are not approval for medication. The terms require users to be at least eighteen. The semaglutide FAQ describes general eligibility as BMI thirty or above, or twenty-seven or above with a weight-related condition, subject to the clinician’s individual assessment. Those thresholds do not guarantee acceptance or establish the appropriate treatment for a particular history. Ask what evaluation is required, how check-ins occur, and whether additional visits or laboratory work would change the bill. Prescriva advertises all fifty states and the District of Columbia, but its terms qualify access by the service, professional licensure, telehealth law and dispensing restrictions. Confirm availability for your actual location and selected medication before paying. Broad geographic marketing does not promise every service to every applicant. The consent says OpenLoop’s clinical consent controls conflicts about clinical practice; ask for the applicable care documents as well as the platform subscription terms.
Costs, billing and cancellation
The semaglutide page lists $249 per month month-to-month and a 48-week plan from $194 per month. Tirzepatide lists $339 per month month-to-month and a 24-week plan from $289 per month. Keep each plan label attached to its price: the lower amounts are longer-plan equivalents, not established month-to-month rates. The pricing page corroborates the $249 and $339 injection cards and separately advertises a $90 saving with twelve-week plans. Yet its comparison still says from $109 per month, and another savings block says from $289 per month. Those inconsistent banners do not establish a universal standard-injection quote. The public material reviewed did not resolve the longer plans’ full charge, number of payments, billing cadence, dose coverage or early-exit settlement. Multiplying a week count into calendar-month payments would create a total the source does not establish. Request an itemized initial debit, subsequent charges, renewal date and amount owed if treatment ends early. The terms allow monthly, quarterly or otherwise specified recurring billing and describe thirty days notice before subscription price increases. Save the actual selected agreement rather than relying on a card that describes a different commitment. A low monthly headline is not enough to compare these commitments. Ask whether cancellation ends only future renewals or also releases any remaining long-plan obligation, and whether a changed prescription alters the discounted amount. Keep the response alongside the selected agreement so the proposed saving can be weighed against the actual payment responsibility.
Medication and evidence
The product pages explicitly advertise compounded semaglutide and tirzepatide injections. Compounded preparations are not FDA-approved; ingredient names alone do not establish equivalence to an approved branded product. Ask for the exact formulation, concentration, prescribed dose, quantity, supplies, storage instructions and pharmacy contact before judging value. The advertised inclusion of dose adjustments does not establish that every dose has identical pricing. A monthly support promise also needs a practical explanation of how a clinical concern reaches the prescriber. Prescriva’s refund policy starts the subscription and first charge after completion of the intake assessment. For medical disqualification, it promises a refund of the most recent billing cycle only. The terms instead describe a consultation-fee refund. These scopes conflict, so obtain a written answer about which components of your payment would return if the clinician declines treatment. Do not budget on an unqualified full-refund guarantee. The refund policy also provides potential full refunds for stock unavailability without a suitable alternative and an assessment left unreviewed beyond its stated timeframe. Completed consultations, dispensed or shipped medication and unused portions of a cycle are generally nonrefundable. The consent treats medicine as dispensed when the pharmacy signs it out for shipping, before delivery. Cancellation through the dashboard or the support contact listed in the refund policy is described as immediately processed with no advance-notice requirement, effective at the current cycle’s end. Auto-renewal still requires cancellation before the next payment. Retain confirmation of the effective date and next-charge status. Refund requests are reviewed within five business days; approved funds may take five to ten business days to appear. Damaged or incorrect shipments prompt replacement coordination rather than a general right to return medication.
Sources checked October 25, 2026
- Semaglutide monthly and 48-week offers
- Tirzepatide monthly and 24-week offers
- Injection cards and conflicting comparison prices
- Cancellation and medical-disqualification refund policy
- Operator, clinical network, pharmacies and subscription terms
- Clinical review, auto-renewal and dispensing milestone
Pros and watch-outs
What we like
- Distinct month-to-month injection offers
- Names clinical network and possible pharmacies
- Public dashboard and email cancellation channels
- Describes included support and dose adjustments
Watch-outs
- Long-plan total and exit terms unresolved
- Residual price banners conflict
- Medical-disqualification refund scopes differ
- Actual practice and pharmacy vary by order
Best for
Adults comparing monthly compounded injection offers who will confirm the care assignment and obtain written payment and refund terms.
Who should look elsewhere
People relying on the smallest banner as a flexible monthly rate or needing a guaranteed full medical-denial refund.
Research relevant to Prescriva
Explore the evidence and its limits. Findings apply to the formulation, route and population studied; they do not establish the quality or effectiveness of a provider’s products.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4 and SELECT, plus oral and higher-dose semaglutide trials: weight loss, withdrawal, cardiovascular benefit and the limits of comparison.
- SURMOUNT-1 explained: the trial that made tirzepatide the benchmark
The landmark phase 3 trial of tirzepatide for obesity — the design, the up-to-20.9% weight loss, the safety profile, and the limits of what it proved.
How Prescriva compares
A few alternatives worth a look, depending on what you’re optimizing for.
MadeMedCompounded injection or sublingual options with disclosed clinical partners
See MadeMed →Shed
A wide range of GLP-1 formats (injection, drops, lozenges, microdose)
See Shed →
RoBranded treatment with medication insurance navigation
See Ro →
More GLP-1 telehealth reviews: Wholesome ClinicZera HealthZYP Medical1st OptimalZipHealthShapely
Editorial research
How we assessed this. This review reflects Aminoscope’s own read of Prescriva’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Are $194 and $289 flexible monthly prices?
- They are advertised equivalents for the 48-week semaglutide and 24-week tirzepatide plans. Observed month-to-month offers are $249 and $339 respectively; the longer-plan total and payment schedule require confirmation.
- Will medical disqualification refund everything?
- The refund policy promises the latest billing cycle, while the terms describe the consultation fee. The conflict prevents an unqualified full-refund promise; obtain the scope in writing.
- Which pharmacy fills my prescription?
- The terms name RedRock Pharmacy, Health Warehouse and Precision Medicine as possible partners. Confirm the actual pharmacy assigned to your order; the list is not independent credential verification.
- Is Prescriva legit?
- Prescriva is a GLP-1 telehealth service. The medications it names are Compounded semaglutide and Compounded tirzepatide. Its stated availability: All 50 states and DC advertised, subject to service, clinician and dispensing availability. What it publishes up front: Month-to-month sema $249/mo, tirz $339/mo; longer-plan equivalents and refund scopes differ. Before you pay, ask in writing about a single monthly price you can check before an intake, whether it bills insurance and how its intake works.